Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Correlation between systemic allergen desensitisation and long-term asthma protection in mice following intravenous administration of the live tuberculosis vaccine MTBVAC

  • Calvo, Silvia
  • Rodrigo-Muñoz, Jose Manuel
  • Tarancón, Raquel
  • Uranga, Santiago
  • Martín, Carlos
  • Pozo, Victoria del
  • Aguiló, Nacho
Background MTBVAC is a live attenuated tuberculosis vaccine, currently undergoing phase III evaluation for tuberculosis prevention. In previous preclinical studies, we found that local pulmonary administration of MTBVAC via the intranasal route had a strong therapeutic effect against asthma. This effect correlated with the abrogation of allergen-specific Th2 response in the lungs. Methods Using different mouse models of asthma, we investigated the effect of MTBVAC administered by intravenous (IV) route and its potential as immunotherapeutic agent to induce desensitisation of allergen-specific responses at a systemic level. We explored the effects of this process in the efficacy against airway hyperresponsiveness (AHR) induced by exposure to different allergens. Findings IV MTBVAC was highly efficient at reducing AHR induced by different allergens. Additionally, IV MTBVAC was found to be well-tolerated, being progressively eliminated from the different organs analysed. From a mechanistic standpoint, we observed that MTBVAC intravenous, but not intranasal, impaired allergen-specific Th2 response in both lungs and spleen. This reduction at a systemic level correlated with long-term therapeutic protection against allergen exposure. Our results also revealed differential immunological mechanisms governing systemic and local pulmonary allergen desensitisation processes. Notably, in a cohort of patients with asthma sensitive to house dust mite (HDM), in vitro incubation of peripheral blood mononuclear cells (PBMCs) with MTBVAC prevented allergen-specific production of Th2 cytokines IL-4 and IL-5. Interpretation Altogether, our results suggest that intravenous MTBVAC could be a plausible allergen desensitising approach for treatment of asthma, and could provide long-term protection against allergen exposure.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

NK cells mediate preventive efficacy of intravenous BCG against lung metastasis in mice

  • Guerrero, Claudia
  • Casal, Marta
  • Alierta, Cristina
  • Moreo, Eduardo
  • Araujo-Voces, Miguel
  • Uranga, Santiago
  • Gómez, Ana Belén
  • Martín, Carlos
  • Aguiló, Nacho
Lung metastases frequently arise from primary tumors, including bladder cancer, and represent a critical negative prognostic factor. Natural Killer (NK) cells have shown to play a vital role in controlling metastasis. Consequently, tumor cells have evolved specific mechanisms to evade NK cell-mediated immune surveillance, promoting metastasis and resistance to immunotherapy. In this study, we investigated the prophylactic and therapeutic potential of intravenous Bacillus Calmette–Guerin (BCG) in preventing lung metastases from bladder cancer cells using a murine model. We demonstrated that prophylactic BCG administration significantly reduced tumor burden and prolonged survival, largely through NK cell activation. However, BCG treatment was ineffective when administered over established tumors, likely due to tumor-driven immune evasion mechanisms. Our results revealed the contribution of interferon-gamma (IFN-γ) to tumor resistance. Tumor cells exposed to IFN-γ were more resistant to BCG in vivo, which correlated with the overexpression of immune checkpoint molecules, whereas disruption of the IFN-γ signaling pathway in tumor cells partially restored the therapeutic efficacy of BCG. Our findings highlight the importance of understanding tumor immune escape mechanisms and suggest that BCG could be a promising treatment for preventing lung metastases in bladder cancer.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Factors Involved in Tuberculosis Recurrence in a Low-incidence Setting; Reactivation Predominates Over Reinfection in a 30-year Surveillance Study

  • Lin, Xunxiao
  • Ibarz, Daniel
  • Cebollada, Alberto
  • Martín, Carlos
  • Iglesias, María-José
  • Samper, Sofía
Background Tuberculosis (TB) recurrence remains a significant public health concern, even in regions with low incidence. Recurrent TB may result from endogenous reactivation of a previous infection or from exogenous reinfection with a new strain. Distinguishing between these mechanisms is crucial for understanding TB dynamics and optimizing control strategies. This study aims to determine the frequency of TB recurrence in Arag & oacute;n, Spain, a region with low TB incidence, and to identify factors associated with reactivation and reinfection over a 30-year period.Methods A retrospective, descriptive study including all genotyped Mycobacterium tuberculosis isolates from 1993 to 2022 was conducted in Arag & oacute;n. IS6110-RFLP was the method used to genotype strains. Recurrences were classified as reactivation or reinfection based on molecular profiles. Clinical and epidemiological data were retrieved from medical records. Appropriate statistical tests were applied to compare groups.Results Among 3510 genotyped TB cases, 81 (2.30%) were recurrent: 68 reactivations (1.93%) and 15 reinfections (0.42%). Reinfection was significantly associated with change of residence, HIV infection, cancer diagnosis in the second episode, and multimorbidity. Time to recurrence was significantly longer in reinfections (median 7.0 years) compared to reactivations (2.0 years). Most isolates belonged to Lineage 4 , and reinfection strains were more often linked to clustered strains circulating in the community.Conclusions In this low-incidence setting, TB recurrence is rare and mainly the result of reactivation. Reinfections, though less frequent, are linked to mobility, HIV co-infection, neoplasm, and compromised health status. These findings underscore the importance of long-term molecular surveillance and targeted follow-up for high-risk patients. Tuberculosis recurrence in Arag & oacute;n (1993-2022) was rare (2.30%). Reactivation predominated over reinfection, which was associated with mobility, HIV, cancer status, and multimorbidity. Molecular surveillance and targeted follow-up are essential to address recurrence dynamics in low-incidence settings.